Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 93 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7084271

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Aug 1, 2006 · Expires Jul 27, 2026

    granted
  2. US 7084159

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 1, 2006 · Expires Jul 27, 2026

    granted
  3. US 7078209

    CAK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  4. US 7078525

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  5. US 7074782

    Carbamate caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  6. US 7074924

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  7. US 7074765

    Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  8. AU 2001289696

    New use of lipase inhibitors

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] · Granted Jul 6, 2006 · Expires Jul 1, 2026

    granted
  9. US 7067661

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  10. US 7060733

    Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species

    The Regents of the University of California · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  11. US 7056944

    Pyrazole compositions useful as inhibitors of erk

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  12. US 7053119

    Methods for identifying and using IKK inhibitors

    The Regents of the University of California · Granted May 30, 2006 · Expires May 25, 2026

    granted
  13. US 7053057

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 30, 2006 · Expires May 25, 2026

    granted
  14. AU 2002212120

    Lipase inhibitors for the treatment of dyspepsia

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] · Granted May 11, 2006 · Expires May 6, 2026

    expired
  15. US 7041687

    Indazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 9, 2006 · Expires May 4, 2026

    expired
  16. US 7037912

    Protein kinase inhibitors

    Theravance, Inc. · Granted May 2, 2006 · Expires Apr 27, 2026

    expired
  17. US 7015212

    Thiazepine inhibitors of HIV-1 integrase

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 21, 2006 · Expires Mar 16, 2026

    expired
  18. US 7008948

    Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 7, 2006 · Expires Mar 2, 2026

    expired
  19. US 6995261

    4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  20. US 6994868

    Compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  21. US 6995141

    Interleukin 1β protease and interleukin 1β protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  22. US 6989385

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2006 · Expires Jan 19, 2026

    expired
  23. US 6977241

    SH2 domain binding inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 20, 2005 · Expires Dec 15, 2025

    expired
  24. US 6974809

    Inhibitors of interleukin 1-β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2005 · Expires Dec 8, 2025

    expired